MEPSEVII

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Croatia, Estonia, France, Ireland, Italy, Japan, Lithuania, Poland, Spain.

Active ingredients

The drug MEPSEVII contains one active pharmaceutical ingredient (API):

1	Vestronidase alfa UNII 7XZ4062R17 - VESTRONIDASE ALFA
	Vestronidase alfa is a recombinant form of human betaglucuronidase (GUS) and is intended to provide exogenous GUS enzyme for uptake into cellular lysosomes and subsequent catabolism of accumulated glycosaminoglycans (GAGs) in affected tissues.
	Read more about Vestronidase alfa

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MEPSEVII Concentrate for solution for infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A16AB18		A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AB Enzymes
Discover more medicines within A16AB18

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	597321070000117
EE	Ravimiamet	1778340
ES	Centro de información online de medicamentos de la AEMPS	1181301001
FR	Base de données publique des médicaments	61759695
IT	Agenzia del Farmaco	047006010
JP	医薬品医療機器総合機構	3959427A1020
LT	Valstybinė vaistų kontrolės tarnyba	1086090
PL	Rejestru Produktów Leczniczych	100410670
US	FDA, National Drug Code	69794-001